| 44.73 BATS BZX Real-Time Price As of 1:21pm ET |  -0.86 / -1.89%Today’s Change | 37.43 Today|||52-Week Range 46.25 | +4.02% Year-to-Date |
| Previous close | 45.59 |
| Today’s open | 44.87 |
| Day’s range | 44.67 - 45.01 |
| Volume | 76,563 |
| Average volume (3 months) | 1,671,510 |
| Market cap | $114.3B |
| Earnings growth (last year) | -15.68% |
| Earnings growth (this year) | -6.48% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +5.92% |
| P/E ratio | 30.7 |
| Price/Sales | 2.76 |
| Price/Book | 1.64 |
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +1.25 | +1.11% |
| AZNAstraZeneca | -0.27 | -0.66% |
| GSKGlaxoSmithKline | -0.37 | -0.90% |
| ABTAbbott Laboratories | -2.08 | -2.86% |
| Next reporting date | February 7, 2019 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $39.5B |
| Annual profit (last year) | $4.3B |
| Net profit margin | 10.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Olivier Brandicourt |
Chief Financial Officer & Executive Vice President Jean-Baptiste Chasseloup de Chatillon |
Corporate headquarters Paris, Ile-de-france |
